Cambridge Investment Research Advisors Inc. cut its stake in shares of National Health Investors, Inc. (NYSE:NHI – Free Report) by 7.1% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 7,361 shares of the real estate investment trust’s stock after selling 565 shares during the period. Cambridge Investment Research Advisors Inc.’s holdings in National Health Investors were worth $544,000 as of its most recent SEC filing.
A number of other institutional investors have also made changes to their positions in NHI. Jones Financial Companies Lllp boosted its position in shares of National Health Investors by 781.2% during the fourth quarter. Jones Financial Companies Lllp now owns 890 shares of the real estate investment trust’s stock worth $62,000 after buying an additional 789 shares during the period. Charles Schwab Investment Management Inc. boosted its position in National Health Investors by 2.9% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 876,839 shares of the real estate investment trust’s stock valued at $60,765,000 after purchasing an additional 24,462 shares during the last quarter. Victory Capital Management Inc. raised its stake in National Health Investors by 21.8% in the fourth quarter. Victory Capital Management Inc. now owns 29,723 shares of the real estate investment trust’s stock valued at $2,060,000 after buying an additional 5,318 shares during the period. Arizona State Retirement System raised its stake in National Health Investors by 7.3% in the fourth quarter. Arizona State Retirement System now owns 13,412 shares of the real estate investment trust’s stock valued at $929,000 after buying an additional 908 shares during the period. Finally, Raymond James Financial Inc. bought a new position in shares of National Health Investors during the fourth quarter worth approximately $2,219,000. 62.51% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
NHI has been the topic of a number of analyst reports. Truist Financial raised National Health Investors from a “hold” rating to a “buy” rating and set a $77.00 price target on the stock in a research report on Wednesday, July 2nd. Wedbush raised National Health Investors to a “strong-buy” rating in a research note on Wednesday, July 2nd. Two research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $85.75.
National Health Investors Price Performance
NYSE:NHI opened at $70.34 on Thursday. The firm has a market capitalization of $3.28 billion, a price-to-earnings ratio of 22.33, a P/E/G ratio of 3.54 and a beta of 0.73. National Health Investors, Inc. has a 52-week low of $65.13 and a 52-week high of $86.13. The stock has a fifty day moving average of $72.56 and a 200 day moving average of $71.60. The company has a debt-to-equity ratio of 0.88, a quick ratio of 16.55 and a current ratio of 16.55.
National Health Investors (NYSE:NHI – Get Free Report) last released its quarterly earnings data on Monday, May 5th. The real estate investment trust reported $1.15 EPS for the quarter, topping the consensus estimate of $1.13 by $0.02. National Health Investors had a return on equity of 10.64% and a net margin of 41.15%. The firm had revenue of $68.87 million for the quarter, compared to the consensus estimate of $85.13 million. During the same quarter in the previous year, the business earned $1.10 earnings per share. The company’s quarterly revenue was up 9.6% on a year-over-year basis. On average, research analysts expect that National Health Investors, Inc. will post 4.41 EPS for the current fiscal year.
National Health Investors Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, August 1st. Shareholders of record on Monday, June 30th will be paid a dividend of $0.90 per share. The ex-dividend date is Monday, June 30th. This represents a $3.60 dividend on an annualized basis and a yield of 5.12%. National Health Investors’s dividend payout ratio is presently 114.29%.
National Health Investors Profile
Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Recommended Stories
- Five stocks we like better than National Health Investors
- What is a support level?
- Tesla Stock Could Accelerate on New EV Tax Legislation
- 3 Healthcare Dividend Stocks to Buy
- Why Marvell Could Be the Smartest AI Bet Under $80
- What Are Growth Stocks and Investing in Them
- Navigating Solar Headwinds: 3 Stocks Built to Last
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.